| Julianne Marie Mitchell, LMFT | |
|
36 Mill Plain Rd, Suite 306, Danbury, CT 06811-5181 | |
| (203) 205-0039 | |
| Not Available |
| Full Name | Julianne Marie Mitchell |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 36 Mill Plain Rd, Danbury, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265539852 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 000781 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Julianne Marie Mitchell, LMFT 6 Carol Ann Dr, Newtown, CT 06470-2317 Ph: (203) 270-7622 | Julianne Marie Mitchell, LMFT 36 Mill Plain Rd, Suite 306, Danbury, CT 06811-5181 Ph: (203) 205-0039 |
News Archive
Buoyed by the extraordinary progress being made by the ALS Therapy Development Institute, the Muscular Dystrophy Association today announced a new milestone-driven grant of $2.5 million, adding to the $18 million MDA already has invested with ALS TDI - the world's only non-profit research center focused exclusively on developing treatments for amyotrophic lateral sclerosis (ALS).
Scientists from the Florida campus of The Scripps Research Institute have been awarded $2.1 million from the National Institute of Neurological Disorders and Stroke of The National Institutes of Health (NIH) to study a protein that has been closely linked in animal models to Parkinson's disease and Huntington's disease.
AMRI announced today that a third compound being developed under its license and research agreement with Bristol-Myers Squibb Company will proceed into preclinical development. AMRI will receive a $750,000 payment from Bristol-Myers Squibb for the completion of this milestone, marking the fifth milestone payment in the ongoing research collaboration between the two companies.
Women with early-stage breast cancer face three late breast cancer consequences: disease recurrence within the conserved breast, development of a contralateral breast cancer, and manifestation of distant metastases. Although local therapy with surgery and radiotherapy is used to minimize the first possibility, adjuvant systemic therapy may theoretically reduce the likelihood of all three events.
Adding the novel insulin-like growth factor 1 receptor inhibitor figitumumab to the epidermal growth factor receptor–tyrosine kinase inhibitor erlotinib does not improve survival in patients with non-adenocarcinoma non-small-cell lung carcinoma, research shows.
› Verified 1 days ago
Ms. Michelle Beck, M.S., L.M.F.T. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 57 North St, Suite 419, Danbury, CT 06810 Phone: 203-778-3838 Fax: 203-778-4040 | |
Tiffany Ivette Gonzalez, MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 75 West St, Danbury, CT 06810 Phone: 203-748-5689 | |
Ms. Georgina E Rescigno, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 5 Kilian Drive, Danbury, CT 06811 Phone: 203-744-3388 | |
Ms. Jacqueline M. Mcnamee, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 75 West St, Danbury, CT 06810 Phone: 203-240-5514 Fax: 203-924-2643 | |
Cristina Zorn, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 84 Hospital Ave, Danbury, CT 06810 Phone: 203-792-6060 Fax: 203-794-9556 | |
Susan Valentino-hersey, MA Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 75 West St, Danbury, CT 06810 Phone: 203-885-5421 |